Adam D. Cutler - Dec 14, 2023 Form 4 Insider Report for Mural Oncology plc (MURA)

Role: Chief Financial Officer
Signature: /s/ Maiken Keson-Brookes, attorney-in-fact for Adam D. Cutler
Stock symbol: MURA
Transactions as of: Dec 14, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/18/2023, 04:30 PM
Previous filing: Nov 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MURA	Ordinary Shares	Award	$0	+78.9K		$0.00	78.9K	Dec 14, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MURA	Stock Option (right to buy)	Award	$0	+146K		$0.00	146K	Dec 14, 2023	Ordinary Shares	146K	$3.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of ordinary shares issuable under 78,859 restricted stock units ("RSUs"). Each RSU represents the right to receive one ordinary share upon vesting. The RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of October 30, 2023, subject to the reporting person's continued service with the Issuer.
F2	This option was granted on December 14, 2023. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on October 30, 2024 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer.